Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0001511 (
Adhesion
)
5,955
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A heparin-binding glycoprotein was purified from conditioned medium of cultured rat Schwann cells. The protein,
p200
, which has an apparent molecular mass of approximately 200 kDa, was identified by its ability to bind the cell surface heparan sulfate proteoglycan N-syndecan (syndecan-3) in a membrane overlay assay. Soluble heparin but not chondroitin sulfate inhibited the binding, suggesting the involvement of heparan sulfate chains of proteoglycan in the interaction. Purified
p200
promoted the attachment and spreading of Schwann cells.
Adhesion
to
p200
was blocked by heparin, suggesting that heparan sulfate proteoglycans are cell surface receptors for
p200
. The tissue distribution of
p200
was determined by immunoblot analysis with anti-
p200
antibodies. Among neonatal rat tissues examined
p200
was detected only in sciatic nerve and, at lower levels, in skeletal muscle.
p200
expression in sciatic nerve was detectable only during the first 2-3 weeks of postnatal development and was not detected in adult rats. Immunofluorescent staining of rat sciatic nerve showed that
p200
was localized in the extracellular matrix surrounding individual Schwann cells-axon units. Two tryptic peptides from
p200
were purified and sequenced. These contained multiple GXX collagen-like repeats. Bacterial collagenase digestion of
p200
produced a product with an apparent molecular mass of approximately 90 kDa. These data suggest that Schwann cells secrete an apparently novel collagen-like adhesive protein that interacts with cells through cell surface heparan sulfate proteoglycans.
...
PMID:Schwann cells secrete a novel collagen-like adhesive protein that binds N-syndecan. 866 84